Published 2017 | Version v1
Publication

Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets.

Citation

An error occurred while generating the citation.

Additional details

Created:
May 13, 2023
Modified:
December 1, 2023